Active matrix metalloprotease-9 in and migration pattern of dendritic cells matured in clinical grade culture conditions

Immunobiology

Volumn 206, Issue 4, 2002, Pages 441-458

  Hollender, Patrick ^a   Ittelet, Danielle ^b   Villard, Florence ^d   Eymard, Jean Christophe ^c   Jeannesson, Pierre ^a   Bernard, Jacky ^b  

^a Faculte de Pharmacie   (France)

^b Unité De Thérapie Cellulaire

^c INSTITUT JEAN GODINOT   (France)

^d ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD83 ANTIGEN; CHEMOKINE; GELATIN; GELATINASE B; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MATRIGEL; TISSUE INHIBITOR OF METALLOPROTEINASE 1; BATIMASTAT; BETA CHEMOKINE; CCL20 PROTEIN, HUMAN; CCR6 PROTEIN, HUMAN; CHEMOKINE RECEPTOR; DRUG DERIVATIVE; GELATINASE A; MACROPHAGE INFLAMMATORY PROTEIN; PHENYLALANINE; PROTEINASE INHIBITOR; THIOPHENE DERIVATIVE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ANTIGEN PURIFICATION; ARTICLE; CELL ASSAY; CELL CULTURE; CELL DIFFERENTIATION; CELL INVASION; CELL MATURATION; CELL MIGRATION; CELL TRANSPORT; CONTROLLED STUDY; DENDRITIC CELL; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LYMPH NODE; MICROSCOPY; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; ZYMOGRAPHY; CELL MOTION; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

CELL DIFFERENTIATION; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINES, CC; DENDRITIC CELLS; HUMANS; MACROPHAGE INFLAMMATORY PROTEINS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; PHENYLALANINE; PROTEASE INHIBITORS; RECEPTORS, CHEMOKINE; THIOPHENES; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 0036774410     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1078/0171-2985-00193     Document Type: Article

References (70)

1. CELLA, M., F. SALLUSTO, and A. LANZAVECCHIA. 1997. Origin, maturation and antigen presenting function of dendritic cells. Curr. Opin, Immunol. 9: 10.
2. BANCHEREAU, J., F. BRIERE, C. CAUX, J. DAVOUST, S. LEBECQUE, Y. J. LIU, B. PULENDRAN, and K. PALUCKA. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18: 767.
3. LANZAVECCHIA, A., and F. SALLUSTO. 2001. Regulation of T cell immunity by dendritic cells. Cell 106: 263.
4. SOGN, J. A. 1998. Tumor immunology: the glass is half full. Immunity 9: 757.
5. FLAMAND, V., T. SORNASSE, K. THIELEMANS, C. DEMANET, M. BAKKUS, H. BAZIN, F. TIELEMANS, O. LEO, J. URBAIN, and M. MOSER. 1994. Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. Eur. J. Immunol. 24: 605
6. MAYORDOMO, J. I., T. ZORINA, W. J. STORKUS, L. ZITVOGEL, C. CELLUZZI, L. D. FALO, C. J. MELIEF, S. T. ILDSTAD, W. M. KAST, and A. B. DELEO et al. 1995. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nat. Med. 1: 1297.
7. PAGLIA, P., C. CHIODONI, M. RODOLFO, and M. P. COLOMBO. 1996. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J. Exp. Med. 183: 317.
8. ZITVOGEL, L., J. I. MAYORDOMO, T. TJANDRAWAN, A. B. DELEO, M. R. CLARKE, M. T. LOTZE, and W. J. STORKUS. 1996. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J. Exp. Med. 183: 87.
9. + hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha. J. Exp. Med. 184: 695.
10. SALLUSTO, F., and A. LANZAVECCHIA. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179: 1109.
11. + blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc. Natl. Acad. Sci. USA 93: 2588.
12. ROMANI, N., S. GRUNER, D. BRANG, E. KAMPGEN, A. LENZ, B. TROCKENBACHER, G. KONWA-LINKA, P. O. FRITSCH, R. M. STEINMAN, and G. SCHULER. 1994. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180: 83.
13. DHODAPKAR, M. V., R. M. STEINMAN, M. SAPP, H. DESAI, C. FOSSELLA, J. KRASOVSKY, S. M. DONAHOE, P. R. DUNBAR, V. CERUNDOLO, D. F. NIXON, and N. BHARDWAJ. 1999. Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells. J. Clin. Invest. 104: 173.
14. ANDERSEN, M. H., P. KEIKAVOUSSI, E. B. BROCKER, B. SCHULER-THURNER, M. JONASSEN, I. SONDERGAARD, P. T. STRATEN, J. C. BECKER, and E. KAMPGEN. 2001. Induction of systemic CTL responses in melanoma patients by dendritic cell vaccination: cessation of CTL responses is associated with disease progression. Int. J. Cancer 94: 820.
15. SCHNURR, M., P. GALAMBOS, C. SCHOLZ, F. THEN, M. DAUER, S. ENDRES, and A. EIGLER. 2001. Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines. Cancer Res. 61: 6445.
16. FRIEDL, P., K. S. ZANKER, and E. B. BROCKER. 1998. Cell migration strategies in 3-D extracellular matrix: differences in morphology, cell matrix interactions, and integrin function. Microsc. Res. Tech. 43: 369.
17. JANCIC, C., H. E.,CHULUYAN, A. MORELLI, A. LARREGINA, E. KOLKOWSKI, M. SARACCO, M. BARBOZA, W. S. LEIVA, and L. FAINBOIM. 1998. Interactions of dendritic cells with fibronectin and endothelial cells. Immunology 95: 283.
18. AMMON, C., S. P. MEYER, L. SCHWARZFISCHER, S. W. KRAUSE, R. ANDREESEN, and M. KREUTZ. 2000. Comparative analysis of integrin expression on monocyte-derived macrophages and monocyte-derived dendritic cells. Immunology 100: 364.
19. LIN, C. L., R. M. SURI, R. A. RAHDON, J. M. AUSTYN, and J. A. ROAKE. 1998. Dendritic cell chemotaxis and transendothelial migration are induced by distinct chemokines and are regulated on maturation. Eur. J. Immunol. 28: 4114.
20. BERNARD, J., D. ITTELET, A. CHRISTOPH, G. POTRON, J. C. ADJIZIAN, S. KOCHMAN, and M. LOPEZ. 1998. Adherent-free generation of functional dendritic cells from purified blood monocytes in view of potential clinical use. Hematol. Cell. Ther. 40: 17.
21. NOEL, A., C. GILLES, K. BAJOU, L. DEVY, F. KEBERS, J. M. LEWALLE, E. MAQUOI, C. MUNAUT, A. REMACLE, and J. M. FOIDART. 1997. Emerging roles for proteinases in cancer. Invasion Metastasis 17: 221.
22. BREW, K., D. DINAKARPANDIAN, and H. NAGASE. 2000. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim. Biophys. Acta 1477: 267.
23. BENDER, A., M. SAPP, G. SCHULER, R. M. STEINMAN, and N. BHARDWAJ. 1996. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J. Immunol. Methods 196: 121.
24. DEVY, L., P. HOLLENDER, C. MUNAUT, A. COLIGE, R. GARNOTEL, J. M. FOIDART, A. NOÊL, and P. JEANNESSON. 2002. Matrix and serine protease expression during leukemic cell differentiation induced by aclacinomycin and all-trans-retinoic acid. Biochem. Pharmacol. 63: 179.
25. GRAHAM, J. M. 1993. Isolation of membranes from tissue culture cells. Methods Mol. Biol. 19: 97.
26. HEUSSEN, C., and E. B. DOWDLE. 1980. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal. Biochem. 102: 196.
27. ZHOU, L. J., and T. F. TEDDER. 1995. A distinct pattern of cytokine gene expression by human CD83+ blood dendritic cells. Blood 86: 3295.
28. SALLUSTO, F., and A. LANZAVECCHIA, 1999. Mobilizing dendritic cells for tolerance, priming, and chronic inflammation. J. Exp. Med. 189: 611.
29. GALE, L. M., and S. R. MCCOLL. 1999. Chemokines: extracellular messengers for all occasions? Bioessays 21: 17.
30. DIEU, M. C., B. VANBERVLIET, A. VICARI, J. M. BRIDON, E. OLDHAM, S. AIT-YAHIA, F. BRIERE, A. ZLOTNIK, S. LEBECQUE, and C. CAUX. 1998. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med. 188: 373.
31. KELLERMANN, S. A., S. HUDAK, E. R. OLDHAM, Y. J. LIU, and L. M. MCEVOY. 1999. The CC chemokine receptor-7 ligands 6Ckine and macrophage inflammatory protein-3 beta are potent chemoattractants for in vitro- and in vivo-derived dendritic cells. J. Immunol. 162: 3859.
32. BOTOS, I., L. SCAPOZZA, D. ZHANG, L. A. LIOTTA, and E. F. MEYER. 1996. Batimastat, a potent matrix mealloproteinase inhibitor, exhibits an unexpected mode of binding. Proc. Natl. Acad. Sci. USA 93: 2749.
33. FRIEDL, P., and E. B. BROCKER. 2000. The biology of cell locomotion within three-dimensional extracellular matrix. Cell. Mol. Life Sci. 57: 41.
34. OPDENAKKER, G., P. E. VAN DEN STEEN, and J. VAN DAMME. 2001. Gelatinase B: a tuner and amplifier of immune functions. Trends Immunol. 22: 571.
35. MURPHY, G., H. STANTON, S. COWELL, G. BUTLER, V. KNAUPER, S. ATKINSON, and J. GAVRILOVIC. 1999. Mechanisms for pro matrix metalloproteinase activation. APMIS 107: 38.
36. KAMMERER, U., M. SCHOPPET, A. D. MCLELLAN, M. KAPP, H. I. HUPPERTZ, E. KAMPGEN, and J. DIETL. 2000. Human decidua contains potent immunostimulatory CD83(+) dendritic cells. Am. J. Pathol. 157: 159.
37. DE SAINT-VIS, B., J. VINCENT, S. VANDENABEELE, B. VANBERVLIET, J. J. PIN, S. AIT-YAHIA, S. PATEL, M. G. MATTEI, J. BANCHEREAU, S. ZURAWSKI, J. DAVOUST, C. CAUX, and S. LEBECQUE. 1998. A novel lysosome-associated membrane glycoprotein, DC-LAMP, induced upon DC maturation, is transiently expressed in MHC class II compartment. Immunity 9: 325.
38. PUIG-KROGER, A., F. SANZ-RODRIGUEZ, N. LONGO, P. SANCHEZ-MATEOS, L. BOTELLA, J. TEIXIDO, C. BERNABEU, and A. L. CORBI. 2000. Maturation-dependent expression and function of the CD49d integrin on monocyte-derived human dendritic cells. J. Immunol. 165: 4338.
39. + dendritic cells: the levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation. J. Immunol. 161: 2804.
40. EBNER, S., G. RATZINGER, B. KROSBACHER, M. SCHMUTH, A. WEISS, D. REIDER, R. A. KROCZEK, M. HEROLD, C. HEUFLER, P. FRITSCH, and N. ROMANI. 2001. Production of IL-12 by human monocyte-derived dendritic cells is optimal when the stimulus is given at the onset of maturation, and is further enhanced by IL-4. J. Immunol. 166: 633.
41. + T cells. J. Immunol. 166: 3865.
42. + human blood dendritic cells for active tumor immunotherapy. Exp. Hematol. 25: 232.
43. RIESER, C., C. PAPESH, M. HEROLD, G. BOCK, R. RAMONER, H. KLOCKER, G. BARTSCH, and M. THURNHER. 1998. Differential deactivation of human dendritic cells by endotoxin desensitization: role of tumor necrosis factor-alpha and prostaglandin E2. Blood 91: 3112.
44. VERDIJK, R. M., T. MUTIS, B. ESENDAM, J. KAMP, C. J. MELIEF, A. BRAND, and E. GOULMY. 1999. Polyriboinosinic polyribocytidylic acid (poly(I:C)) induces stable maturation of functionally active human dendritic cells. J. Immunol. 163: 57.
45. KRUSE, M., O. ROSORIUS, F. KRATZER, D. BEVEC, C. KUHNT, A. STEINKASSERER, G. SCHULER, and J. HAUBER. 2000. Inhibition of CD83 cell surface expression during dendritic cell maturation by interference with nuclear export of CD83 mRNA. J. Exp. Med. 191: 1581.
46. REA, D., C. VAN KOOTEN, K. E. VAN MEIJGAARDEN, T. H. OTTENHOFF, C. J. MELIEF, and R. OFFRINGA. 2000. Glucocorticoids transform CD40-triggering of dendritic cells into an alternative activation pathway resulting in antigen-presenting cells that secrete IL- 10. Blood 95: 3162.
47. STEINBRINK, K., L. PARAGNIK, H. JONULEIT, T. TUTING, J. KNOP, and A. H. ENK. 2000. Induction of dendritic cell maturation and modulation of dendritic cell-induced immune responses by Prostaglandins. Arch. Dermatol. Res. 292: 437.
48. + T cells. J. Immunol. 165: 1182.
49. BANCHEREAU, J., B. SCHULER-THURNER, A. K. PALUCKA, and G. SCHULER. 2001. Dendritic cells as vectors for therapy. Cell 106: 271.
50. KLEINMAN, H. K., M. L. MCGARVEY, L. A. LIOTTA, P. G. ROBEY, K. TRYGGVASON, and G. R. MARTIN. 1982. Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. Biochemistry 21: 6188.
51. PIETSCHMANN, P., P. HAHN, S. KUDLACEK, R. THOMAS, and M. PETERLIK. 2000. Surface markers and transendothelial migration of dendritic cells from elderly subjects. Exp. Gerontol. 35: 213.
52. BIANCHI, G., G. D'AMICO, L. VARONE, S. SOZZANI, A. MANTOVANI, and P. ALLAVENA. 2000. In vitro studies on the trafficking of dendritic cells through endothelial cells and extracellular matrix. Dev. Immunol. 7: 143.
53. SATO, K., H. KAWASAKI, H. NAGAYAMA, M. ENOMOTO, C. MORIMOTO, K. TADOKORO, T. JUJI, and T. A. TAKAHASHI. 2000. TGF-beta 1 reciprocally controls chemotaxis of human peripheral blood monocyte-derived dendritic cells via chemokine receptors. J. Immunol. 164: 2285.
54. GUYRE, C. A., J. L. FISHER, M. G. WAUGH, P. K. WALLACE, C. G. TRETTER, M. S. ERNSTOFF, and R. J. BARTH. 2002. Advantages of hydrophobic culture bags over flasks for the generation of monocyte-derived dendritic cells for clinical applications. J. Immunol. Methods 262: 85.
55. DE BRUIJN, M. L., D. H. SCHUURHUIS, M. P. VIERBOOM, H. VERMEULEN, K. A. DE COCK, M. F. OOMS, M. E. RESSING, M. TOEBES, K. L. FRANKEN, J. W. DRIJFHOUT, T. H. OTTENHOFF, R. OFFRINGA, and C. J. MELIEF. 1998. Immunization with human papillomavirus type 16 (HPV16) oncoprotein-loaded dendritic cells as well a protein in adjuvant induces MHC class I-restricted protection to HPV16-induced tumor cells. Cancer Res. 58: 724.
56. CHIODONI, C., P. PAGLIA, A. STOPPACCIARO, M. RODOLFO, M. PARENZA, and M. P. COLOMBO, 1999. Dendritic cells infiltrating tumors cotransduced with granulocyte/macrophage colony-stimulating factor (GM-CSF) and CD40 ligand genes take up and present endogenous tumor-associated antigens, and prime naive mice for a cytotoxic T lymphocyte response. J. Exp. Med. 190: 125.
57. DHODAPKAR, M. V., J. KRASOVSKY, R. M. STEINMAN, and N. BHARDWAJ. 2000. Mature dendritic cells boost functionally superior CD8(+) T-cell in humans without foreign helper epitopes. J. Clin. Invest. 105: R9.
58. +T cells. Nat. Immunol. 2: 1010.
59. LARSSON, M., D. T. WILKENS, J. F. FONTENEAU, T. J. BEADLE, M. J. MERRITT, R. G. KOST, P. A. HASLETT, S. CU-UVIN, N. BHARDWAJ, D. F. NIXON, and B. L. SHACKLETT, 2002. Amplification of low-frequency antiviral CD8 T cell responses using autologous dendritic cells. Aids 16: 171.
60. Grillet, B., J. DEQUEKER, L. PAEMEN, B. VAN DAMME, and G. OPDENAKKER. 1997. Gelatinase B in chronic synovitis: immunolocalization with a monoclonal antibody. Br. J. Rheumatol. 36: 744.
61. BARTHOLOME, E. J., I. VAN AELST, E. KOYEN, R. KISS, F. WILLEMS, M. GOLDMAN, and G. OPDENAKKER. 2001. Human monocyte-derived dendritic cells produce bioactive gelatinase B: inhibition by IFN-beta. J Interferon Cytokine Res. 21: 495.
62. OSMAN, M., M. TORTORELLA, M. LONDEI, and S. QUARATINO. 2002. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases define the migratory characteristics of human monocyte-derived- dendritic cells. Immunology 105: 73.
63. BOURGUIGNON, L. Y., Z. GUNJA-SMITH, N. IIDA, H. B. ZHU, L. J. YOUNG, W. J. MULLER, and R. D. CARDIFF. 1998. CD44v(3,8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells. J. Cell Physiol. 176: 206.
64. NAGASE, H. 1998. Cells surface activation of progelatinase A (proMMP-2) and cell migration. Cell Res 8: 179.
65. YU, Q., and I. STAMENKOVIC. 2000. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 14: 163.
66. GUNZER, M., E. KAMPGEN, E. B. BROCKER, K. S. ZANKER, and P. FRIEDL. 1997. Migration of dendritic cells in 3D-collagen lattices. Visualisation of dynamic interactions with the substratum and the distribution of surface structures via a novel confocal reflection imaging technique. Adv. Exp. Med. Biol. 417: 97.
67. ZLOTNIK, A., and O. YOSHIE. 2000. Chemokines: a new classification system and their role in immunity. Immunity 12: 121.
68. AUSTYN, J. M. 2000. Antigen-presenting cells. Experimental and clinical studies of dendritic cells. Am. J. Respir. Crit. Care Med. 162: S146.
69. JOHNATTY, R. N., D. D. TAUB, S. P. REEDER, S. M. TURCOVSKI-CORRALES, D. W. COTTAM, T. J. STEPHENSON, and R. C. REES. 1997. Cytokine and chemokine regulation of proMMP-9 and TIMP-1 production by human peripheral blood lymphocytes. J. Immunol. 158: 2327.
70. JANOWSKA-WIECZOREK, A., L. A. MARQUEZ, A. DOBROWSKY., M. Z. RATAJCZAK, and M. L. CABUHAT. 2000. Differential MMP and TIMP production by human marrow and peripheral blood CD34(+) cells in response to chemokines. Exp. Hematol. 28: 1274.